[144] TransDigm Group INC SEC Filing

Rhea-AI Filing Summary

TransDigm Group (TDG) has a Form 144 notice for the potential sale of 230 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE. The filing lists an aggregate market value of $305,410.10 for these shares and notes that 56,318,584 common shares were outstanding at the time referenced. The 230 shares were acquired on 11/21/2025 by exercising stock options for cash on the same date.

The notice also details recent activity under a Rule 10b5-1 trading plan for The Fortuna Trust, including common stock sales of 1,104 shares on 11/20/2025, 7,191 shares on 11/18/2025, and 700 shares on 10/27/2025, with disclosed gross proceeds for each transaction. The signatory represents that they are not aware of undisclosed material adverse information about the issuer.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	230	305410.10	56318584	11/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/21/2025	Exercise of Stock Options	Issuer			230	11/21/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for THE FORTUNA TRUST U/T/A DTD 06/01/2018 1350 Euclid Avenue, Suite 1600 Cleveland OH 44115	Common	11/20/2025	1104	1502423.47
10b5-1 Sales for THE FORTUNA TRUST U/T/A DTD 06/01/2018 1350 Euclid Avenue, Suite 1600 Cleveland OH 44115	Common	11/18/2025	7191	9791047.47
10b5-1 Sales for THE FORTUNA TRUST U/T/A DTD 06/01/2018 1350 Euclid Avenue, Suite 1600 Cleveland OH 44115	Common	10/27/2025	700	952000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the TDG Form 144 filing disclose about planned share sales?

The notice discloses a potential sale of 230 shares of TransDigm Group common stock on the NYSE through Morgan Stanley Smith Barney LLC, with an aggregate market value of $305,410.10.

How were the 230 TDG shares in the Form 144 acquired?

The 230 common shares were acquired on 11/21/2025 via an exercise of stock options from the issuer, with payment made in cash on the same date.

How many TransDigm (TDG) shares were outstanding as referenced in the filing?

The Form 144 states that 56,318,584 shares of TransDigm common stock were outstanding as of the time referenced for this notice.

What recent TDG stock sales under Rule 10b5-1 are reported for The Fortuna Trust?

The filing lists sales for The Fortuna Trust of 1,104 shares on 11/20/2025, 7,191 shares on 11/18/2025, and 700 shares on 10/27/2025, all common stock with specified gross proceeds.

What representation does the seller make about TDG in this Form 144?

The person for whose account the securities are to be sold represents that they do not know of any material adverse information about TransDigm’s current or prospective operations that has not been publicly disclosed.

Is the TDG Form 144 sale connected to a Rule 10b5-1 trading plan?

The document references 10b5-1 sales for The Fortuna Trust and provides dates and amounts of those sales, indicating they were conducted under a Rule 10b5-1 trading plan.